Eligibility for sacubitril–valsartan in patients with acute decompensated heart failure

Eligibility for sacubitril–valsartan in patients with acute decompensated heart failure

Abstract Aims Large‐scale clinical trials have demonstrated clinical benefits of sacubitril–valsartan in symptomatic heart failure with reduced ejection fraction patients (PARADIGM‐HF), with potential benefits in patients hospitalized for acute decompensated heart failure (ADHF) (PIONEER‐HF) and few...

Full description

Bibliographic Details
Main Authors: David Carballo, Jérôme Stirnemann, Nicolas Garin, Chistophe Marti, Jacques Serratrice, Sebastian Carballo
Format: Article
Language:English
Published: Wiley 2020-06-01
Series:ESC Heart Failure
Subjects:
Heart failure
Acute
Sacubitril‐valsartan
Online Access:https://doi.org/10.1002/ehf2.12676

Internet

https://doi.org/10.1002/ehf2.12676

Similar Items